Incorporation of strontium up to 5 mol. (%) to hydroxyapatite did not affect its cytocompatibility

Materials Research

Volumn 14, Issue 4, 2011, Pages 456-460

  Dos Santos Tavares, Débora ^a   Resende, Cristiane Xavier ^a   Quitan, Maíra Paiva ^a   De Oliveira Castro, Letícia ^b   Granjeiro, José Mauro ^b,c   De Almeida Soares, Gloria ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

Cytotoxicity; Hydroxyapatite; Strontium

Indexed keywords

CELL VIABILITY; CRYSTAL VIOLET; CYTOCOMPATIBILITY; CYTOTOXICITY ASSAYS; DEHYDROGENASE ACTIVITY; FTIR; MEMBRANE INTEGRITY; NEUTRAL RED; PHYSICO-CHEMICAL CHARACTERIZATION; PHYSICOCHEMICAL PROPERTY; THEORETICAL VALUES; X RAY FLUORESCENCE; XRD;

APATITE; CHEMICAL PROPERTIES; CYTOTOXICITY; HYDROXYAPATITE; INFRARED SPECTROSCOPY; X RAY DIFFRACTION;

STRONTIUM;

EID: 84555217834     PISSN: 15161439     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-14392011005000073     Document Type: Article

References (37)

1. Dorozhkin SV. Calcium orthophosphates. Journal of Materials Science: Materials in Medicine. 2007;42(4):1061-1095.
2. Vallet-Regi M and Gonzalez-Calbet JM. Calcium phosphates as substitution of bone tissues. Progress in Solid State Chemistry. 2004;32(1-2):1-31. http://dx.doi.org/10.1016/j.progsolidstchem.2004.07.001
3. Calasans-Maia MD, Rossi AM, Dias EP, Santos S R A, Áscoli F and Granjeiro J. M. Stimulatory effect on osseous repair of zinc-substituted hydroxyapatite: histological study in rabbit's tibia. Key Engineering Materials. 2008;20(2):1269-1272. http://dx.doi.org/10.4028/www.scientific.net/KEM.361-363. 1269
4. Lima IR, Santos S R A, Santiago DL, Rossi AM and Granjeiro JM. Cytotoxicity analysis of apatites modified with divalent metals. Key Engineering Materials. 2008;20(2):1135-1138. http://dx.doi.org/10.4028/www.scientific.net/ KEM.361-363.1135
5. Wopenka B and Pasteris JD. A mineral perspective on the apatite in bone. Materials Science and Engineering C. 2005;25(2):131-143. http://dx.doi.org/10. 1016/j.msec.2005.01.008
6. Ingham E and Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials. 2005;26(11):1271-1286. PMid:15475057. http://dx.doi.org/10.1016/j.biomaterials.2004.04.035 (Pubitemid 39314501)
7. Verberckmoes SC, Behets GJ, Oste L, Bervoets AR, Lamberts LV, Drakopoulos M et al. Effects of strontium on the physicochemical characteristics of hydroxyapatite. Calcified Tissue International. 2004;75(5):405-415. PMid:15592797. http://dx.doi.org/10.1007/s00223-004-0260-4 (Pubitemid 40100888)
8. Marie PJ, Garba MT, Hott M and Miravet L. Effect of low doses of stable strontium on bone metabolism in rats. Mineral Electrolyte Metabolism. 1985;11(1):5-13. PMid:3974537. (Pubitemid 15181939)
9. Grympas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M et al. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone. 1996;18(3):253-259. http://dx.doi.org/10.1016/8756-3282(95) 00484-X (Pubitemid 26118122)
10. Marie PJ. Strontium as therapy for osteoporosis. Current Opinion in Pharmacology. 2005;5:633-636. PMid:16183330. http://dx.doi.org/10.1016/j.coph. 2005.05.005 (Pubitemid 41614464)
11. Ni GX, Lu WW, Xu B, Chiu KY, Yang C, Li ZY et al. Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone. Biomaterials. 2006;27(29):5127-5133. PMid:16781769. http://dx.doi.org/10.1016/ j.biomaterials.2006.05.030 (Pubitemid 43928124)
12. Xue-Yang L and De-Min C. Effects of strontium substituted hydroxyapatite of different porosities on osteoblasts in vitro. Journal of Oral Tissue Engineering. 2005;2(2):66-75.
13. Fu YF, Chen DM and Zhang JZ. In vitro study on the cytotoxicity of strontium substituted hydroxyapatite. Shanghai Kou Qiang Yi Xue. 2002;11(3):229-232. PMid:14983257.
14. Capuccini C, Torricelli P, Boanini E, Gazzano M, Giardino R and Bigi A. Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells. Journal of Biomedical Materials Research Part A. 2009;89(3):594-600 PMid:18437694. http://dx.doi.org/10.1002/jbm.a.31975
15. Weyermann J, Lochmann D and Zimmer A. A practical note on the use of cytotoxicity assays. International Journal of Pharmaceutics. 2005;288:369-376. PMid:15620877. http://dx.doi.org/10.1016/j. ijpharm.2004.09.018 (Pubitemid 40038590)
16. International Organization for Standardization - ISO. ISO 10993-5: Biological evaluation of medical devices. Geneva: ISO; 1999. part 5: Tests for cytotoxicity: In vitro methods.
17. International Organization for Standardization - ISO. ISO 10993-12: Biological evaluation of medical devices. Geneva: ISO; 1996. Part 12: Sample preparation and reference materials.
18. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research. 1988;48(17):4827-4833. PMid:3409223.
19. Winckler J. Vital staining of lysossomes and other cell organelles of the rat with neutral red. Progress in Histochemistry and Cytochemistry. 1974;6(3):1-91.
20. Kueng W, Silber E and Eppenberger U. Quantification of cells cultured on 96-well plates. Analytical Biochemistry. 1989;182(1):16-19. http://dx.doi.org/ 10.1016/0003-2697(89) 90710-0 (Pubitemid 19251274)
21. Bigi A, Boanini E, Capuccini C and Gazzano M. Strontium-substituted hydroxyapatite nanocrystals. Inorganica Chimica Acta. 2007;360(3):1009-1016. http://dx.doi.org/10.1016/j.ica.2006.07.074
22. Kim HW, Koh YH, Kong YM, Kang JG and Kim HE. Strontium substituted calcium phosphate biphasic ceramics obtained by a powder precipitation method. Journal of Materials Science: Materials in Medicine. 2004;15(10):1129-1134. PMid:15516874. http://dx.doi.org/10.1023/B:JMSM.0000046395.76435.60
23. Gibson IR, Rehman I, Best SM and Bonfield W. Characterization of the transformation from calcium-deficient apatite to β-tricalcium phosphate. Journal of Materials Science: Materials in Medicine. 2000;11(12):799-804. PMid:15348063. http://dx.doi.org/10.1023/A:1008905613182 (Pubitemid 32014534)
24. Dagang G, Kewei X, Xiaoyun Z and Yong H. Development of a strontium-containing hydroxyapatite bone cement. Biomaterials. 2005;26(19) 4073-4083. PMid:15664634. http://dx.doi.org/10.1016/j. biomaterials.2004.10.032
25. Fanovich MA and Porto Lopez JM. Influence of temperature and additives on the microstructure and sintering behaviour of hydroxyapatites with different Ca/P ratios. Journal of Materials Science: Materials in Medicine. 1998;9(1):53-60. PMid:15348702. http://dx.doi.org/10.1023/A:1008834712212 (Pubitemid 28031772)
26. Christoffersen J, Christoffersen MR, Kolthoff N and Barenholdt O. Effects of strontium Ions on Growth and Dissolution of Hydroxyapatite and on Bone Mineral Detection. Bone. 1997;20(1):47-54. http://dx.doi.org/10.1016/S8756- 3282(96) 00316-X (Pubitemid 27046019)
27. Zhang W, Shen Y, Pan H, Lin K, Liu X, Darvell BW et al. Effects of strontium in modified biomaterials. Acta Biomaterialia. 2011;7:800-808. PMid:20826233. http://dx.doi.org/10.1016/j.actbio.2010.08.031
28. Landi E, Tampieri A, Celotti G, Vichi and Sandri M. Influence of synthesis and sintering parameters on the characteristics of carbonate apatite. Biomaterials. 2004;25(10):1763-1770. PMid:14738839. http://dx.doi.org/10.1016/j. biomaterials.2003.08.026 (Pubitemid 38102252)
29. Chiba K, Kawakami K and Tohyama K. Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicology in Vitro. 1998;12(3):251-258. http://dx.doi.org/10.1016/S0887- 2333(97) 00107-0 (Pubitemid 28331388)
30. De-Deus G, Canabarro A, Alves G, Linhares A, Senne MI and Granjeiro JM. Optimal cytocompatibility of a bioceramic nanoparticulate cement in primary human mesenchymal cells. Journal of Endodontics. 2009;35(10):1387-1390. PMid:19801236. http://dx.doi.org/10.1016/j.joen. 2009.06.022
31. Capuccini C, Torricelli P, Sima F, Boanini E, Ristoscu C, Bracci B et al. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In vitro osteoblast and osteoclast response. Acta Biomaterialia. 2008;4(6):1885-1893. PMid:18554996. http://dx.doi.org/10.1016/j.actbio.2008.05. 005
32. 2+ on strontium substituted hydroxyapatite's (Sr-HA) cytotoxicity. Journal of Oral Tissue Engineering. 2005;2:76-80.
33. Weichang X, Moore JL, Hosick HL, Bose S, Bandyopadhyay A, Lu WW et al. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics. Journal of Biomedical Materials Research Part A. 2006;7(4):804-814. (Pubitemid 44915901)
34. Takamori ER, Figueira EA, Taga R, Sogayar MC and Granjeiro JM. Evaluation of the Cytocompatibility of Mixed Bovine Bone. Brazilian Dental Journal. 2007;18(3):179-184. PMid:18176706. http://dx.doi.org/10.1590/S0103- 64402007000300001
35. Murray PE, Godoy CG and Godoy FG. How is the biocompatibility of dental biomaterials evaluated? Medicina Oral, Patología Oral y Cirurgía Bucal. 2007;12(E2): 258-266.
36. Ciapetti G, Granchi D, Verri E, Savarino L, Cavedagna D and Pizzoferrato, A. Application of a combination of neutral red and amino Black staining for rapid, reliable cytotoxicity testing of biomaterials. Biomaterials. 1996;17(13):1259-1264. http://dx.doi.org/10.1016/0142-9612(96) 88670-4 (Pubitemid 26187033)
37. Ohkuma S and Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. Journal of Cell Biology. 1981;90(3):656-664. PMid:7287819. http://dx.doi.org/10.1083/jcb. 90.3.656 (Pubitemid 12254921)